Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1977 Apr;28(1):1–18.

Synergy, additivism and antagonism in immunosuppression. A critical review.

M C Berenbaum
PMCID: PMC1540873  PMID: 324671

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addison I. E., Berenbaum M. C. The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer. 1971 Mar;25(1):172–181. doi: 10.1038/bjc.1971.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERENBAUM M. C., BROWN I. N. THE EFFECT OF DELAYED ADMINISTRATION OF FOLINIC ACID ON IMMUNOLOGICAL INHIBITION BY METHOTREXATE. Immunology. 1965 Mar;8:251–259. [PMC free article] [PubMed] [Google Scholar]
  3. BIEBER S., ELION G. B., HITCHINGS G. H., HOOPER D. C., NATHAN H. C. Suppression of the immune response by drugs in combination. Proc Soc Exp Biol Med. 1962 Nov;111:334–337. doi: 10.3181/00379727-111-27783. [DOI] [PubMed] [Google Scholar]
  4. Bareham C. R., Griswold D. E., Calabresi P. Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse. Cancer Res. 1974 Mar;34(3):571–575. [PubMed] [Google Scholar]
  5. Batchelor J. R., Fabre J., Morris P. J. Passive enhancement of kidney allografts: potentiation with antithymocyte serum. Transplantation. 1972 Jun;13(6):610–613. doi: 10.1097/00007890-197206000-00010. [DOI] [PubMed] [Google Scholar]
  6. Berenbaum M. C., Cope W. A., Double J. A. The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide. Clin Exp Immunol. 1973 Jun;14(2):257–270. [PMC free article] [PubMed] [Google Scholar]
  7. Berenbaum M. C. Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents. Br J Cancer. 1969 Jun;23(2):426–433. doi: 10.1038/bjc.1969.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brent L., Medawar P. Quantitative studies on tissue transplantation immunity. 8. The effects of irradiation. Proc R Soc Lond B Biol Sci. 1966 Oct 11;165(1001):413–423. doi: 10.1098/rspb.1966.0074. [DOI] [PubMed] [Google Scholar]
  9. CHIN P. H., SILVERMAN M. S. The effect of whole body x-irradiation of mice on immunity to tetanus toxoid. II. The delayed immune response to injections of tetanus toxoid. J Immunol. 1956 Oct;77(4):266–270. [PubMed] [Google Scholar]
  10. Cerilli J., Hattan D. The effect of combined immunosuppressive agents and cell-free antigen on xenograft survival. Transplantation. 1972 Aug;14(2):207–210. doi: 10.1097/00007890-197208000-00009. [DOI] [PubMed] [Google Scholar]
  11. Davies D. A. The true mechanism of immunologic enhancement, deduced from studies of heart transplants in rats. Transplant Proc. 1976 Mar;8(1):37–39. [PubMed] [Google Scholar]
  12. Fischer D. S., Cassidy E. P., Welch A. D. Immunosuppression by pyrimidine nucleoside analogs. Biochem Pharmacol. 1966 Aug;15(8):1013–1022. doi: 10.1016/0006-2952(66)90265-6. [DOI] [PubMed] [Google Scholar]
  13. Floersheim G. L. A study of combined treatment with chemical immunosuppressants and antilymphocytic serum to prolong skin allograft survival. Transplantation. 1969 Oct;8(4):392–402. doi: 10.1097/00007890-196910000-00011. [DOI] [PubMed] [Google Scholar]
  14. Friedman E. A., Gelfand M., Bernheimer H. P. Synergism in immunosuppression. I. Effect of methylprednisolone, azathioprine, chlorambucil, and radiation on tetanus antitoxin production. Transplantation. 1971 May;11(5):479–486. [PubMed] [Google Scholar]
  15. GOLDIN A., MANTEL N. The employment of combinations of drugs in the chemotherapy of neoplasia: a review. Cancer Res. 1957 Aug;17(7):635–654. [PubMed] [Google Scholar]
  16. Gelfand M. C., Steinberg A. D., Nagle R., Knepshield J. H. Therapeutic studies in NZB-W mice. I. Synergy of azathioprine, cyclophosphamide and methylprednisolone in combination. Arthritis Rheum. 1972 May-Jun;15(3):239–246. doi: 10.1002/art.1780150304. [DOI] [PubMed] [Google Scholar]
  17. Gelfand M. C., Steinberg A. D. Therapeutic studies in NZB-W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisolone. Arthritis Rheum. 1972 May-Jun;15(3):247–252. doi: 10.1002/art.1780150305. [DOI] [PubMed] [Google Scholar]
  18. Glucksberg H., Fefer A. Combination chemotherapy for clinically established graft-versus-host disease in mice. Cancer Res. 1973 Apr;33(4):859–861. [PubMed] [Google Scholar]
  19. HANSEN H. J., VANDEVOORDE J. P., BENNETT K. J., GILES W. G., NADLER S. B. AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS. J Lab Clin Med. 1964 May;63:801–818. [PubMed] [Google Scholar]
  20. Hyman L. R., Kovacs K., Steinberg A. D. Drug-induced tolerance: selective induction with immunosuppressive drugs and their synergistic interaction. Int Arch Allergy Appl Immunol. 1975;48(2):248–260. doi: 10.1159/000231311. [DOI] [PubMed] [Google Scholar]
  21. Koene R. A., Gerlag P. G., McKenzie I. F., Hagemann J. F., Wijdeveld P. G. Enhancement of skin grafts in the mouse. The combined used of specific and nonspecific immunosuppression. Transplantation. 1975 Sep;20(3):241–247. doi: 10.1097/00007890-197509000-00009. [DOI] [PubMed] [Google Scholar]
  22. LOEWE S. Antagonisms and antagonists. Pharmacol Rev. 1957 Jun;9(2):237–242. [PubMed] [Google Scholar]
  23. LOEWE S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953 Jun;3(6):285–290. [PubMed] [Google Scholar]
  24. MCKNEALLY M. F., KELLY W. D., RESNICK J., MARTINEZ C. INDUCTION OF TOLERANCE WITH DISRUPTED ANTIGEN, IMURAN, AND SUBLETHAL IRRADIATION. Surg Forum. 1964;15:131–132. [PubMed] [Google Scholar]
  25. Mendelsohn J., Multer M. M., Boone R. F. Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol. J Clin Invest. 1973 Sep;52(9):2129–2137. doi: 10.1172/JCI107397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Monaco A. P., Codish S. D. Survey of the current status of the clinical uses of antilymphocyte serum. Surg Gynecol Obstet. 1976 Mar;142(3):417–426. [PubMed] [Google Scholar]
  27. ROSENBERG S., CALABRESI P. ENHANCED SUPPRESSION OF THE SECONDARY IMMUNE RESPONSE BY COMBINATION OF 6-MERCAPTOPURINE DUAZOMYCIN A'. Nature. 1963 Sep 14;199:1101–1102. doi: 10.1038/1991101a0. [DOI] [PubMed] [Google Scholar]
  28. ROTH F. J., Jr, FRIEDMAN J., SYVERTON J. T. Effects of roentgen radiation and cortisone on susceptibility of mice to Candida albicans. J Immunol. 1957 Feb;78(2):122–127. [PubMed] [Google Scholar]
  29. Russell P. S. Immunological enhancement. Transplant Proc. 1971 Mar;3(1):960–966. [PubMed] [Google Scholar]
  30. SYVERTON J. T., WERDER A. A., FRIEDMAN J., ROTH F. J., Jr, GRAHAM A. B., MIRA O. J. Cortisone and roentgen radiation in combination as synergistic agents for production of lethal infections. Proc Soc Exp Biol Med. 1952 May;80(1):123–128. doi: 10.3181/00379727-80-19543. [DOI] [PubMed] [Google Scholar]
  31. Schrek R., Stefani S. S. Cytarabine: cytocidal effect on normal and leukemic lymphocytes. Synergism with x rays and comparison with mechlorethamine. Exp Mol Pathol. 1976 Feb;24(1):84–90. doi: 10.1016/0014-4800(76)90059-9. [DOI] [PubMed] [Google Scholar]
  32. TALIAFERRO W. H., TALIAFERRO L. G. THE RELATION OF RADIATION DOSAGE TO ENHANCEMENT, DEPRESSION, AND RECOVERY OF THE INITIAL FORSSMAN HEMOLYSIN RESPONSE IN RABBITS. J Infect Dis. 1964 Oct;114:285–303. doi: 10.1093/infdis/114.4.285. [DOI] [PubMed] [Google Scholar]
  33. Vogel C. L., Calabresi P. Enhanced suppression of experimental allergic encephalomyelitis by combination chemotherapy with duazomycin-A and 6-mercaptopurine. Proc Soc Exp Biol Med. 1969 May;131(1):251–256. doi: 10.3181/00379727-131-33852. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES